Skip to main content
ARTC logo

Art Technology Acquisition Corp. (ARTC) Stock Price & Analysis

Art Technology Acquisition Corp. (ARTC) — MoonshotScore 65/100 (Strong band), calculated Nov 18, 2026. Price $10.05 (+0.20%), as of the Nov 19, 2026 trading session; market cap $350M.

Educational signal · not a buy or sell recommendation · How to read this

$10.05 +$0.02 (+0.20%) Market Cap $350M

Art Technology Acquisition Corp. · ARTC · NASDAQ

ArthroCare Corp. specializes in developing and marketing minimally invasive surgical devices, primarily focused on soft tissue repair. Their products are used in arthroscopic procedures to address conditions affecting joints and related tissues.

Price as of Nov 19, 2026

Key Statistics

65 of 100

MoonshotScore v2 · Art Technology Acquisition (ARTC)

Strong
Business Quality n/a Not scored: the profitability, margin and return-on-capital inputs were not available for this company in the latest run.
Financial Safety Fortress (84)
Valuation n/a Not scored: the valuation-multiple and yield inputs were not available for this company in the latest run.
Growth Durability n/a Not scored: the revenue, earnings and cash-flow growth inputs were not available for this company in the latest run.
Momentum Rising (64)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Too few pillars have data for a confident read — treat the score as provisional. Business Quality: n/a; Financial Safety: Fortress; Valuation: n/a; Growth Durability: n/a; Momentum: Rising.

Helping: balance-sheet strength

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for ARTC (57 recorded, newest six shown)
RecordedScoreBand
65Fair
65Strong
65Strong
65Strong
65Strong
65Strong

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$10.05
Change on the day+0.20%
Market capitalisation$350M—
Shares traded on the day5.4K

Price & events

Other perspectives

Council score for Art Technology Acquisition (ARTC): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

2-Factor Breakdown

Financial Safety Strong
Momentum Moderate

Legends Council

5 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Unfavorable read

Read on: Nov 14, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Neutral
Margin of Safety Fairly Valued

Read on: Aug 31, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Aug 31, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Art Technology Acquisition (ARTC), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Art Technology Acquisition Corp. (ARTC) is listed on NASDAQ. It employs 3 people. The market values it at $350M.

3 · Financial strengths and risks

What are the financial strengths and risks for Art Technology Acquisition (ARTC)?

Short answer · as of

The MoonshotScore pillars rate balance-sheet strength as strengths. Trailing ratios: current ratio 0.09.

5 · Peer comparison

How does Art Technology Acquisition compare with its peers?

Short answer

Art Technology Acquisition's score ranks 4th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Johnson & Johnson (JNJ) Named competitor$272.70 Nov 18, 2026$656B83 5-pillar Nov 18, 2026
Medtronic plc (MDT) Named competitor$100.72 Nov 18, 2026$129B81 5-pillar Nov 18, 2026
Boston Scientific Corporation (BSX) Named competitor$42.99 Nov 19, 2026$62.3B77 5-pillar Nov 18, 2026
Art Technology Acquisition (ARTC) — this page$10.05$350M65
Cohen Circle Acquisition Corp. II (CCII) Same industry, near in market value$10.35 Nov 19, 2026$359M55 5-pillar Nov 18, 2026
Oxley Bridge Acquisition Limited (OBA) Same industry, near in market value$10.41 Nov 19, 2026$329M53 5-pillar Nov 18, 2026
Blue Water Acquisition Corp III (BLUW) Same industry, near in market value$10.44 Nov 19, 2026$337M51 5-pillar Nov 18, 2026
Soulpower Acquisition Corp. (SOUL) Same industry, near in market value$10.55 Nov 19, 2026$358M50 5-pillar Nov 18, 2026
Oyster Enterprises II Acquisition Corp (OYSE) Same industry, near in market value$10.48 Nov 19, 2026$355M48 5-pillar Nov 18, 2026
Cantor Equity Partners V, Inc. (CEPV) Same industry, near in market value$10.20 Nov 19, 2026$324M48 5-pillar Nov 18, 2026
Renatus Tactical Acquisition Corp I (RTAC) Same industry, near in market value$10.49 Nov 19, 2026$327M47 5-pillar Nov 18, 2026
Perimeter Acquisition Corp. I Class A Ordinary Shares (PMTR) Same industry, near in market value$10.48 Nov 19, 2026$323M47 5-pillar Nov 18, 2026
Fifth Era Acquisition Corp I Class A Ordinary Shares (FERA) Same industry, near in market value$10.61 Nov 19, 2026$332M46 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held ARTC in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported ARTC in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

Investor Questions: ARTC Stock

These answers are editorial: 1 of these 9 answers is drawn from the ARTC research dossier (written Mar 17, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for ARTC?

ARTC carries the MoonshotScore stated above — the Strong band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. ArthroCare Corp. specializes in developing and marketing minimally invasive surgical devices, primarily focused on soft tissue repair.

Is ARTC a good stock to buy?

Stock Expert AI does not rate ARTC buy, sell or hold. Art Technology Acquisition Corp. carries a MoonshotScore, in the Strong band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the ARTC stock price today?

The last price recorded for Art Technology Acquisition Corp. (ARTC), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

How does ArthroCare Corp. manage patent expiration risks?

ArthroCare Corp. managed patent expiration risks by continuously innovating and developing new products and technologies to replace those that were losing patent protection.

What are the key factors to evaluate for ARTC?

Art Technology Acquisition Corp. (ARTC) holds a MoonshotScore in the moderate range. ArthroCare's product portfolio addresses a range of conditions in sports medicine, spine, and ENT markets. Not financial advice.

How frequently does ARTC data refresh on this page?

ARTC's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven ARTC's recent stock price performance?

Art Technology Acquisition Corp. (ARTC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary Coblation technology. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider ARTC overvalued or undervalued right now?

Art Technology Acquisition Corp. (ARTC) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of ARTC?

Fractional-share availability for Art Technology Acquisition Corp. (ARTC) depends on your brokerage, account and supported securities. Check the broker's current eligibility, minimums and fees before placing an order.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 8 figures on this page — 6 from Financial Modeling Prep (FMP), 1 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.